earnings
ML
NASDAQ · MLYS
Mineralys Therapeutics, Inc.
Healthcare · Biotechnology
$28.02
Up+$0.04 (+0.14%)
Updated Sep 19, 2026, 3:30 AM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.39B
- P/E ratio
- -12.37
- Dividend yield
- 0.00%
- 52-week range
- $22.30 – $47.65
- Volume
- 3.79M
- Avg. volume
- 1.48M
Price performance
MLYS price history
1M range · 20 trading sessions · Daily adjusted prices
MLYS closed at $28.02 after 20 trading sessions, up 9.24% for the selected period.
- Last close
- $28.02
- Period change
- +9.24%
- Period low
- $25.27
- Period high
- $31.12
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $27.77 | $28.13 | $27.38 | $28.02 | 3.79M |
| Sep 17, 2026 | $27.95 | $29.52 | $27.93 | $27.98 | 1.14M |
| Sep 16, 2026 | $28.98 | $29.085 | $27.33 | $27.54 | 1.42M |
| Sep 15, 2026 | $28.58 | $28.985 | $27.55 | $28.91 | 1.78M |
| Sep 14, 2026 | $28.14 | $29.61 | $27.89 | $28.95 | 1.19M |
| Sep 11, 2026 | $29.65 | $29.945 | $28.17 | $28.20 | 1.73M |
| Sep 10, 2026 | $30.04 | $30.57 | $29.20 | $29.30 | 763.76K |
| Sep 9, 2026 | $30.87 | $31.99 | $30.43 | $30.50 | 2.05M |
| Sep 8, 2026 | $28.03 | $31.59 | $28.03 | $31.12 | 2.59M |
| Sep 4, 2026 | $28.00 | $28.35 | $27.395 | $28.21 | 643.52K |
| Sep 3, 2026 | $29.15 | $29.40 | $27.715 | $28.27 | 1.33M |
| Sep 2, 2026 | $25.70 | $29.285 | $25.70 | $29.04 | 2.04M |
| Sep 1, 2026 | $25.47 | $26.33 | $24.98 | $25.57 | 728.42K |
| Aug 31, 2026 | $25.42 | $25.95 | $25.06 | $25.67 | 1.08M |
| Aug 28, 2026 | $25.81 | $26.105 | $25.25 | $25.60 | 812.83K |
| Aug 27, 2026 | $25.86 | $26.24 | $25.53 | $26.01 | 420.75K |
| Aug 26, 2026 | $26.30 | $26.30 | $25.57 | $25.89 | 766.39K |
| Aug 25, 2026 | $25.47 | $26.665 | $25.375 | $26.34 | 863.97K |
| Aug 24, 2026 | $25.68 | $25.86 | $24.95 | $25.27 | 591.2K |
| Aug 21, 2026 | $25.97 | $26.3999 | $25.63 | $25.65 | 699.84K |
Latest MLYS news
The latest Smart Investors Daily articles mentioning MLYS.
Stock researchResearch & News · Analysis
Loading stock research…